Share this article
US Food and Drug Administration to Study Blockchain Healthcare Applications
The US government agency responsible for health and safety is now studying blockchain tech.
By Pete Rizzo
Updated Sep 11, 2021, 12:59 p.m. Published Jan 11, 2017, 2:45 p.m.
The US Food and Drug Administration (FDA), the government agency responsible for approving and regulating medical products, announced today its intent to study blockchain tech.
Revealed in press materials published by IBM Watson Health, the research initiative will find the FDA teaming with IBM to explore how data from electronic medical records, clinical trials and health data from wearable devices could be better shared and audited using a blockchain.
STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters
Initial tests will focus on clinical trials and real-world evidence data related to oncological data, according to the statements.
Overall, the partners positioned the trial as one that could one day mitigate the potential of patient privacy breaches during electric exchanges.
The release reads:
"By keeping an audit trail of all transactions on an unalterable distributed ledger, blockchain technology establishes accountability and transparency in the data exchange process."
According to the release, the IBM and the FDA will work together for two years, with the aim to publish their findings in 2017.
Food and drugs image via Shutterstock
More For You
What to know:
- As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.
- GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.
- Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.
More For You
XRP Faces Downside Risk as Social Sentiment Turns Wildly Negative
The turn in crowd mood comes after a two-month slide of roughly 31%, leaving the token vulnerable to further downside if risk appetite weakens across majors.
What to know:
- XRP's price approached the $2 mark as social sentiment around the token turned sharply negative, according to Santiment data.
- The token has experienced a 31% decline over two months, making it vulnerable to further losses if market risk appetite weakens.
- Santiment's sentiment model indicates XRP is in a 'fear zone,' where negative commentary significantly outweighs positive talk, potentially influencing market positioning.
Top Stories
